Vahh Chemicals Limited is an ISO 9001:2015 certified company engaged in the manufacturing, sourcing, blending, and trading of textile auxiliary chemicals. The company's products are essential for various stages of textile processing, including pre-treatment, dyeing, printing, and finishing. They cater to a wide spectrum of textile substrates such as cotton, polyester, silk, and synthetic blends, offering customized formulations that improve fabric quality, texture, and colour vibrancy, while also imparting functional properties like water repellence and flame resistance. The company operates predominantly on a B2B model, segregated into three main segments. The first is Customized Chemical Blending (contributing 66.59% of FY26 revenues), where chemical formulations are tailored to client-specific fabric and machinery needs. The second is the Trading of Textile Chemicals (8.13% of FY26 revenues), involving the distribution of pre-treatment agents, dyeing auxiliaries, and finishing chemicals. The third is the Nutrition segment (25.27% of FY26 revenues) operated via its subsidiary HSHS Nutraceuticals Limited, which offers dietary and wellness supplements. Vahh Chemicals caters directly to regional dyeing and printing houses. As of March 31, 2026, the company has served over 71 regional and local companies. The company relies on consultative selling and provides post-sales technical support to build long-term relationships. Despite strong customer retention—where 4 of its top 20 clients have been associated for over 3 years—the business experiences moderate customer concentration, with the top 10 customers contributing 68.06% to the total revenue from operations in Fiscal 2026. The company's operations are conducted from its existing unit located at Bhidbhanjan Society, Udhna, Surat, spanning an area of 759.93 sq. ft. The manufacturing process primarily involves the blending of various raw materials using two blenders. Because there is no dedicated machinery for single products, and the same machines are utilized across multiple products to ensure flexibility and quickly adjust to market demands, standard metrics for "capacity utilization" are strictly not applicable to its current operations. To reduce dependency on third-party manufacturers and secure a reliable supply of high-volume, high-margin components like silicones, polysols, and thickeners, the company is using a portion of the IPO proceeds to set up a new backward integration manufacturing facility at Surat. This proposed project will have a dedicated installed production capacity of 1,500 MT per annum. As per financial performance, Vahh Chemicals Limited has posted total income / net profits of Rs 10.16 Cr / Rs 0.34 Cr (FY24), Rs 23.75 Cr / Rs 2.58 Cr (FY25) and Rs 43.19 Cr / Rs 5.09 Cr (FY26). So as per previous financials data, the company has shown good growth, but the trade receivables to total sales ratio is high at around 37.47%, 85.91%, and 38.97% for FY24, FY25, and FY26 respectively. Also, the operating cash flow is negative for FY24 (Rs -2.14 Cr), FY25 (Rs -5.68 Cr), and FY26 (Rs -3.70 Cr). The company has an average EPS of Rs 5.77 and an average RoNW of 34.54% for the last three fiscals. The issue is priced at a P/BV of 1.28 as per the post-issue NAV of Rs 46.78/-. If we attribute the latest earnings of FY24, FY25, and FY26 on equity post-issue, then the asking price is at a P/E of around 146.34, 19.29, and 9.79 respectively. As per the RHP, the comparison between listed peers (Bhatia Colour Chem Limited) is shown in the above table. On the BRLM's front, Marwadi Chandarana Intermediaries Brokers Private Limited is associated with this IPO, and has handled 9 IPOs in the last three fiscal years. From the last 9 IPOs, all 9 opened above the issue price or at par, on the day of listing. As of now, from the last 9 IPOs, five are trading below the issue price and the remaining all are trading above the issue price or at par (as on 01.06.26). As per financials, Vahh Chemicals Limited has shown good growth, RoNW is 32.21% (for FY26) and P/E is 146.34, 19.29 and 9.79 respectively as per FY24, FY25 and FY26 post-issue earnings. So, the issue looks fully priced. But higher trade receivables, massive inventory build-up (230 days), history of statutory defaults, persistent negative operating cash flows and the aggressive 35:1 bonus issue right before the IPO raise severe doubts. The company is primarily engaged in the manufacturing, sourcing, blending, and trading of textile auxiliary chemicals, operating entirely in the B2B segment, which is a highly competitive business segment. Performance of the BRLM has been solid on listing and poor post listing. So, we give an AVOID rating for this IPO. Readers must consult a qualified financial advisor prior to making any actual investment decisions.
✍️ Post a Comment